Skip to main content
. 2021 Aug 2;24(11):894–906. doi: 10.1093/ijnp/pyab053

Figure 2.

Figure 2.

Study timeline. THC=Δ9-tetrahydrocannabinol (THC) assessment, during which rats were assessed in the 30-minute startle paradigm 30 minutes following subcutaneous administration of vehicle or 1 or 3 mg/kg THC; CBD=cannabidiol (CBD) assessment, during which rats were assessed in the same 30-minute startle paradigm 30 minutes following intraperitoneal administration of vehicle or 1, 10, or 30 mg/kg CBD. No injections or startle assessments were administered on days other than those indicated by arrows.